The deregulation of arachidonic acid metabolism in ovarian cancer.
arachidonic acid
biological marker
metabolic pathway
ovarian cancer
targeted therapy
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2024
2024
Historique:
received:
04
02
2024
accepted:
19
04
2024
medline:
20
5
2024
pubmed:
20
5
2024
entrez:
20
5
2024
Statut:
epublish
Résumé
Arachidonic acid (AA) is a crucial polyunsaturated fatty acid in the human body, metabolized through the pathways of COX, LOX, and cytochrome P450 oxidase to generate various metabolites. Recent studies have indicated that AA and its metabolites play significant regulatory roles in the onset and progression of ovarian cancer. This article examines the recent research advancements on the correlation between AA metabolites and ovarian cancer, both domestically and internationally, suggesting their potential use as biological markers for early diagnosis, targeted therapy, and prognosis monitoring.
Identifiants
pubmed: 38764576
doi: 10.3389/fonc.2024.1381894
pmc: PMC11100328
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1381894Informations de copyright
Copyright © 2024 Xia, Gao, Yang, Xing and Ji.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.